Search research articles
Contact Us
Filters
Showing results (851-860 of 863) with videos related to
Page
of 87
Sort By:
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
The New England Journal of Medicine
|
March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
M Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Journal for Immunotherapy of Cancer
|
March 1, 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
International Journal of Surgery (London, England)
|
December 19, 2025
Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines
Núria Lluís, Filipe Kunzler, Levan Tsamalaidze, et al.
Nature
|
September 13, 2019
Early Pleistocene enamel proteome from Dmanisi resolves Stephanorhinus phylogeny
Enrico Cappellini, Frido Welker, Luca Pandolfi, et al.
Oncoimmunology
|
February 1, 2020
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
Alessio Cortellini, Sebastiano Buti, Melissa Bersanelli, et al.
Journal of Cellular and Molecular Medicine
|
March 31, 2022
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Ibrahim El-Battrawy, Filomena Longo, Iván J Núñez Gil, et al.
The Lancet. Diabetes & Endocrinology
|
September 18, 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
Olga Vaccaro, Maria Masulli, Antonio Nicolucci, et al.
IEEE Transactions on Technology and Society
|
December 27, 2022
Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 Patients
Himanshi Allahabadi, Julia Amann, Isabelle Balot, et al.
Nature
|
June 28, 2013
Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse
Ludovic Orlando, Aurélien Ginolhac, Guojie Zhang, et al.
Page
of 87
Search research articles
Search
Showing results (851-860 of 863) with videos related to
Sort By:
Page
of 87
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
The New England Journal of Medicine
|
March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
M Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Journal for Immunotherapy of Cancer
|
March 1, 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
International Journal of Surgery (London, England)
|
December 19, 2025
Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines
Núria Lluís, Filipe Kunzler, Levan Tsamalaidze, et al.
Nature
|
September 13, 2019
Early Pleistocene enamel proteome from Dmanisi resolves Stephanorhinus phylogeny
Enrico Cappellini, Frido Welker, Luca Pandolfi, et al.
Oncoimmunology
|
February 1, 2020
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
Alessio Cortellini, Sebastiano Buti, Melissa Bersanelli, et al.
Journal of Cellular and Molecular Medicine
|
March 31, 2022
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Ibrahim El-Battrawy, Filomena Longo, Iván J Núñez Gil, et al.
The Lancet. Diabetes & Endocrinology
|
September 18, 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
Olga Vaccaro, Maria Masulli, Antonio Nicolucci, et al.
IEEE Transactions on Technology and Society
|
December 27, 2022
Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 Patients
Himanshi Allahabadi, Julia Amann, Isabelle Balot, et al.
Nature
|
June 28, 2013
Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse
Ludovic Orlando, Aurélien Ginolhac, Guojie Zhang, et al.
Page
of 87